RZLT
#3007
Rezolute, Inc. - Common Stock
4.5 0 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.05%
Variación mensual
-0.88%
Variación en los últimos 6 meses
+50.00%
Cambio anual
-37.24%
Cierres anteriores
4.6 9
Open
4.5 0
Mínimo
4.5 0
Máximo
4.5 0
Volumen
63
Financials
- Market Capitalization 433.32 M
- Employee 71
- Founded 2010
- CEO N/A
- Website www.rezolutebio.com
- Headquarter Nevada, United States
- FIGI BBG001XWWHL4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.67
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2990 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.49 USD | +2.62% | +1.10% | +16.07% | +71.03% | 440.32 M USD | ||
| 2994 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.49 USD | -1.96% | -16.94% | +18.06% | +390.18% | 438.12 M USD | ||
| 3019 |  BNTC Benitec Biopharma Inc. - Common Stock | 12.31 USD | +1.15% | -5.45% | +3.71% | -25.89% | 422.90 M USD | ||
| 3021 |  FENC Fennec Pharmaceuticals Inc. - Common Stock | 12.03 USD | -2.59% | +4.34% | +24.79% | +34.41% | 421.86 M USD |